In this review changes of hemostatic parameters in patients with COVID-19 and their practical value are discussed. Current approaches to prevention and treatment of thrombotic/thromboembolic complications in patients with COVID-19 are considered. © 2020 Vserossiiskoe Obshchestvo Kardiologov. All rights reserved.